Presynaptic Inhibition by  2 Receptor/Adenylate Cyclase/PDE4 Complex at Retinal Rod Bipolar Synapse

G-protein-coupled receptor (GPCR)-mediated presynaptic inhibition is a fundamental mechanism regulating synaptic transmission in the CNS. The classical GPCR-mediated presynaptic inhibition in the CNS is produced by direct interactions between the G sub([beta][gamma]) subunits of the G-protein and pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of neuroscience 2014-07, Vol.34 (28), p.9432-9440
Hauptverfasser: Dong, C.-J., Guo, Y., Ye, Y., Hare, W. A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:G-protein-coupled receptor (GPCR)-mediated presynaptic inhibition is a fundamental mechanism regulating synaptic transmission in the CNS. The classical GPCR-mediated presynaptic inhibition in the CNS is produced by direct interactions between the G sub([beta][gamma]) subunits of the G-protein and presynaptic Ca super(2+) channels, K+ channels, or synaptic proteins that affect transmitter release. This mode of action is shared by well known GPCRs such as the [alpha]2, GABA sub(B), and CB sub(1) receptors. We report that the [alpha]2 receptor-mediated inhibition of presynaptic Ca super(2+) channel and transmitter release in rat retinal rod bipolar cells depends on the G sub([alpha]) subunit via a G sub([alpha])-adenylate cyclase-cAMP cascade and requires participation of the type 4 phosphodiesterase (PDE4), a new role for phosphodiesterase in neural signaling. By using the G sub([alpha]) instead of the G sub([beta][gamma]) subunits, this mechanism is able to use a cyclase/PDE enzyme pair to dynamically control a cyclic nucleotide second messenger (i.e., cAMP) for the regulation of synaptic transmission, an operating strategy that shows remarkable similarity to that of dynamic control of cGMP and transmitter release from photoreceptors by the guanylate cyclase/PDE6 pair in phototransduction. Our results demonstrate a new paradigm of GPCR-mediated presynaptic inhibition in the CNS and add a new regulatory mechanism at a critical presynaptic site in the visual pathway that controls the transmission of scotopic information. They also provide a presynaptic mechanism that could contribute to neuroprotection of retinal ganglion cells by [alpha]2 agonists, such as brimonidine, in animal models of glaucoma and retinal ischemia and in glaucoma patients.
ISSN:0270-6474
1529-2401
DOI:10.1523/JNEUROSCI.0766-14.2014